Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
Withdrawn
- Conditions
- Asthma
- First Posted Date
- 2016-06-23
- Last Posted Date
- 2018-11-16
- Lead Sponsor
- Mundipharma Pharmaceuticals B.V.
- Registration Number
- NCT02811315
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Phase 3
Completed
- Conditions
- Pain
- Interventions
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Mundipharma Pharmaceuticals B.V.
- Target Recruit Count
- 113
- Registration Number
- NCT01167127
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Phase 3
Completed
- Conditions
- Pain
- First Posted Date
- 2010-07-22
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Mundipharma Pharmaceuticals B.V.
- Target Recruit Count
- 174
- Registration Number
- NCT01167699
© Copyright 2025. All Rights Reserved by MedPath